Sandra Haberichter

Director, Hemostasis, Senior Investigator
Versiti Blood Research Institute

Presentation(s):

• PB0800 - Quantitative von Willebrand factor multimer analysis in von Willebrand disease patients enrolled in the Zimmerman Program study.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0809 - Performance of the ISTH-BAT bleeding score in a population of newly diagnosed VWD in the U.S. Zimmerman Program

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0810 - A novel role for subtle enhanced VWF clearance in Low VWF pathogenesis highlights limitations of VWFpp/VWF:Ag ratio assessment of clearance.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0812 - Lack of Congruent VWF Levels, Genetics, and Bleeding Symptoms in Families with a Type 1 von Willebrand Disease Diagnosis

  Monday, July 11, 2022
  6:30 PM – 7:30 PM